Explore insights, news, and background stories from the Greater Zurich Area – one of Europe’s most advanced business and innovation hubs. This is where international companies, tech pioneers, and investors find the latest updates on artificial intelligence, robotics, biotech, fintech, and more. Whether you're looking for real-world expansion cases, startup success stories, or key developments in Switzerland’s business environment, our articles offer firsthand perspectives and strategic guidance.
UBS is the best private bank
Zurich – Banking peers have recognized UBS as the best private global bank for the third consecutive year. Euromoney’s annual survey also shows that the Zurich-based banking giant is a leader in innovative technology and other areas.
ETH Domain generates a further 100,000 jobs
Zurich – Each job in the ETH Domain created an additional five jobs in 2016, leading to a further 100,000 jobs overall, finds a new study. The ETH Domain generated a gross value added of more than 13 billion Swiss francs.
EU supports Swiss inventiveness
Researchers programme phages to fight pathogens
Zurich – Researchers at the Federal Institute of Technology (ETH) in Zurich have developed a technology platform that allows them to systematically modify bacteriophages. This marks a major step towards uses phages for therapeutic purposes.
Zedra to open office in Greater Zurich Area
Zurich – Global finance company Zedra will open an office in Zurich in an effort to build its presence in the German-speaking region.
InSphero participates in nanosecurity project
Schlieren ZH - InSphero is participating in an international project to develop safety testing methods for engineered nanomaterials. The aim is to reduce the materials' damaging effect on people and the environment.
U.S. innovation center cooperates with Kenzen
Zizers GR/Santa Clara - The U.S. technology corporation Gore's Innovation Center is joining forces with Kenzen. The partners intend to develop a wearable system that continuously monitors health.
ETH advances medication research
Zurich – Scientists at the ETH have developed a method that increases understanding of the interaction between proteins and metabolic molecules. It could bring great benefits to the pharmaceutical industry. Biognosys is the exclusive license holder.
Cold virus redesigned for cancer therapy
Zurich – Researchers at the University of Zurich have redesigned a cold virus for use in cancer gene therapy. The virus can hide behind a protein shield and specifically infect tumor cells.
Meet with an expansion expert
Our services are free of charge and include:
- Introduction to key contacts in industry, academia, and government
- Advice on regulatory framework, taxes, labor, market, and setting up a company
- Custom-made fact-finding visits, including office and co-working space